- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Praveen Thadani of Priority Health Receives Annual Bernard J. Tyson Health Equity Award
Praveen Thadani, president of Priority Health, has been recognized for his tireless work at reducing health care disparities over a 25-year career with the 2022 Bernard J. Tyson Health Equity Award.
Grand Rapids, Michigan — The Bernard J. Tyson Health Equity Award, established in 2021, has been given this year to Praveen Thadani, president of Priority Health. It was awarded by the Alliance of Community Health Plans.
The annual award honors the late Bernard J. Tyson, former chairman and CEO of Kaiser Permanente, and this year it recognizes Thadani for his career-spanning dedication to increasing health equity and addressing coverage and care disparities among all Americans. He joined Priority Health in 2021.
“I am honored and truly grateful that the good work of Priority Health is being recognized,” said Thadani. "We believe the only way to make a real impact on our communities is to focus on what is at the root of health inequities, like the social determinants of health. We all have the right to live our best lives regardless of the circumstances to which we are born, live, work and age.”
Building Accountability Into GLP-1 Benefit Design: Lessons From Delaware and Philadelphia
August 20th 2025Employers explore glucagon-like peptide-1 (GLP-1) therapies' impact on health benefits, showcasing accountability and data-driven strategies in Philadelphia, Pennsylvania, and Wilmington, Delaware, for sustainable health programs.
Read More
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
GLP-1 Receptor Agonists Reduce Adverse Cardiovascular Outcomes, Improve Survival
August 2nd 2025Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival in those with coronary plaque and after ST-elevation myocardial infarction.
Read More
